Trade Team PEI Multi-Sector Trade Mission to Brazil and Chile
Avivagen Inc.
Avivagen Inc.
Avivagen has a natural and non‐antibiotic product to enhance growth and feed‐conversion for swine and poultry. The novel and patented product, called OxC‐beta, originated at the National Research Council of Canada and is derived from beta‐carotene.
Marketing is beginning in Asia, with it beating antibiotics at improving growth rates, bettering feed‐conversion efficiency and reducing disease.
The CEO would have interest in providing briefing materials and then meeting with you in Brazil to discuss your level of interest in evaluating the inclusion of OxC‐beta into your livestock feeds.
OxC‐betaTM Livestock is derived from beta‐carotene that has been transformed by oxidation into naturally‐occurring polymers that have been shown to prime the immune system to better respond to bacterial challenges while also calming excessive inflammation.
Its physical and functional properties have recently been described in peer‐reviewed scientific journal articles in The Canadian Journal of Chemistry, Public Library of Science One (PLOS ONE) and The American Journal of Veterinary Research.
For feed and livestock producers seeking to eliminate or reduce their use of antibiotics to enhance growth and prevent disease, OxC‐betaTM appears to be a breakthrough product:
- A non‐antibiotic natural ingredient that is supported by peer‐reviewed science.
- Activity at low parts‐per‐million levels in swine and broiler poultry.
- Commercially relevant improvements in weight gain and feed conversion efficiency.
- Protection against common enteric diseases in swine and broiler poultry.
Website
Request a meeting
If you want to connect with a company click here.
